Figure 1.
Schematic model of CRBN E3 ubiquitin ligase in thalidomide-induced teratogenicity. Thalidomide binds to CRBN and inhibits its associated E3 ubiquitin ligase activity. This inhibition results in unknown substrates accumulating and eventually cause developmental defects, partially via downregulation of FGF8 (Ito, et al, 2010).